Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin-Receptor Blockers (ARBs) in Patients at High Risk of Cardiovascular Events: A Meta-Analysis of 10 Randomised Placebo-Controlled Trials

Context. Whether angiotensin converting-enzyme inhibitors (ACEI) and angiotensin-receptor blockers (ARB) are useful in high risk patients without heart failure is unclear. We perform a meta-analysis of prospective randomized placebo-controlled ACEI or ARB trials studying patients with a combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Hean Teik, Ong, Loke Meng, Ho, Jacqueline Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836383/
https://www.ncbi.nlm.nih.gov/pubmed/24307952
http://dx.doi.org/10.1155/2013/478597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836383/
https://www.ncbi.nlm.nih.gov/pubmed/24307952
http://dx.doi.org/10.1155/2013/478597

Ejemplares similares